{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T20:15:22Z","timestamp":1783973722535,"version":"3.55.0"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T00:00:00Z","timestamp":1643846400000},"content-version":"vor","delay-in-days":33,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/j.ctarc.2022.100530","type":"journal-article","created":{"date-parts":[[2022,2,5]],"date-time":"2022-02-05T03:34:17Z","timestamp":1644032057000},"page":"100530","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Extraskeletal myxoid chondrosarcoma: Clinical features and overall survival"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5658-4250","authenticated-orcid":false,"given":"Jeffrey Mark","family":"Brown","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyla","family":"Rakoczy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Pretell-Mazzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ctarc.2022.100530_bib0001","doi-asserted-by":"crossref","first-page":"rjaa503","DOI":"10.1093\/jscr\/rjaa503","article-title":"Extraskeletal myxoid chondrosarcoma: a case report with adjuvant intraoperative treatment","volume":"2020","author":"Bacchetti","year":"2020","journal-title":"J. Surg. Case Rep."},{"issue":"10","key":"10.1016\/j.ctarc.2022.100530_bib0002","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/COC.0000000000000590","article-title":"Extraskeletal myxoid chondrosarcomas: combined modality therapy with both radiation and surgery improves local control","volume":"42","author":"Bishop","year":"2019","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2022.100530_bib0003","doi-asserted-by":"crossref","first-page":"828","DOI":"10.3389\/fonc.2020.00828","article-title":"Extraskeletal myxoid chondrosarcoma: clinical and molecular characteristics and outcomes of patients treated at two institutions","volume":"10","author":"Chiusole","year":"2020","journal-title":"Front. Oncol."},{"issue":"12","key":"10.1016\/j.ctarc.2022.100530_bib0004","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1002\/cncr.23978","article-title":"Extraskeletal myxoid chondrosarcoma: a retrospective review from 2 referral centers emphasizing long-term outcomes with surgery and chemotherapy","volume":"113","author":"Drilon","year":"2008","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.ctarc.2022.100530_bib0005","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1002\/cncr.11162","article-title":"Extraskeletal myxoid chondrosarcoma: a multi-institutional study of 42 cases in Japan","volume":"97","author":"Kawaguchi","year":"2003","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.ctarc.2022.100530_bib0006","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/COC.0000000000000341","article-title":"Benefit of radiotherapy in extraskeletal myxoid chondrosarcoma: a propensity score weighted population-based analysis of the SEER database","volume":"41","author":"Kemmerer","year":"2018","journal-title":"Am. J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.ctarc.2022.100530_bib0007","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/00000478-199906000-00002","article-title":"Extraskeletal myxoid chondrosarcoma: a reappraisal of its morphologic spectrum and prognostic factors based on 117 cases","volume":"23","author":"Meis-Kindblom","year":"1999","journal-title":"Am. J. Surg. Pathol."},{"issue":"10","key":"10.1016\/j.ctarc.2022.100530_bib0008","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s00402-012-1557-9","article-title":"Extraskeletal myxoid chondrosarcoma: a review of 23 patients treated at a single referral center with long-term follow-up","volume":"132","author":"Ogura","year":"2012","journal-title":"Arch. Orthop. Trauma Surg."},{"issue":"8","key":"10.1016\/j.ctarc.2022.100530_bib0009","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/modpathol.3880161","article-title":"Extraskeletal myxoid chondrosarcoma: a clinicopathologic, immunohistochemical, and ploidy analysis of 23 cases","volume":"13","author":"Oliveira","year":"2000","journal-title":"Mod. Pathol."},{"issue":"2","key":"10.1016\/j.ctarc.2022.100530_bib0010","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1245\/s10434-020-08737-7","article-title":"Extraskeletal myxoid chondrosarcoma with molecularly confirmed diagnosis: a multicenter retrospective study within the italian sarcoma group","volume":"28","author":"Paioli","year":"2021","journal-title":"Ann. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.ctarc.2022.100530_bib0011","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/00000421-199504000-00014","article-title":"Extraskeletal myxoid chondrosarcoma. Long-term experience with chemotherapy","volume":"18","author":"Patel","year":"1995","journal-title":"Am. J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.ctarc.2022.100530_bib0012","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1007\/s11999-008-0529-4","article-title":"Local recurrence of disease after unplanned excisions of high-grade soft tissue sarcomas","volume":"466","author":"Potter","year":"2008","journal-title":"Clin. Orthop. Relat. Res."},{"issue":"7","key":"10.1016\/j.ctarc.2022.100530_bib0013","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2106\/JBJS.N.00649","article-title":"Unplanned excision of soft-tissue sarcomas: current concepts for management and prognosis","volume":"97","author":"Pretell-Mazzini","year":"2015","journal-title":"J. Bone Joint Surg. Am."},{"issue":"9","key":"10.1016\/j.ctarc.2022.100530_bib0014","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12092703","article-title":"Extraskeletal myxoid chondrosarcoma: state of the art and current research on biology and clinical management","volume":"12","author":"Stacchiotti","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.ctarc.2022.100530_bib0015","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/S1470-2045(19)30319-5","article-title":"Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial","volume":"20","author":"Stacchiotti","year":"2019","journal-title":"Lancet Oncol."},{"issue":"9","key":"10.1016\/j.ctarc.2022.100530_bib0016","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.ejca.2014.03.013","article-title":"Activity of sunitinib in extraskeletal myxoid chondrosarcoma","volume":"50","author":"Stacchiotti","year":"2014","journal-title":"Eur. J. Cancer"},{"issue":"12","key":"10.1016\/j.ctarc.2022.100530_bib0017","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.6004\/jnccn.2020.0058","article-title":"NCCN guidelines insights: soft tissue sarcoma, version 1.2021","volume":"18","author":"von Mehren","year":"2020","journal-title":"J. Natl. Compr. Canc. Netw."},{"issue":"11","key":"10.1016\/j.ctarc.2022.100530_bib0018","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1158\/1055-9965.EPI-20-0447","article-title":"Long-term outcomes for extraskeletal myxoid chondrosarcoma: a SEER database analysis","volume":"29","author":"Wagner","year":"2020","journal-title":"Cancer Epidemiol. Biomarkers Prev."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294222000211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294222000211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T06:35:09Z","timestamp":1762842909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294222000211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":18,"alternative-id":["S2468294222000211"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2022.100530","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extraskeletal myxoid chondrosarcoma: Clinical features and overall survival","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2022.100530","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100530"}}